Author:
Fitzgerald Sandra,Bhat Basharat,Print Cristin,Jones Gregory T.
Abstract
Abstract
Background & Methods
In this study, a novel restriction enzyme (RE) digestion-based droplet digital polymerase chain reaction (ddPCR) assay was designed for cg005575921 within the AHRR gene body and compared with matching results obtained by bisulfite conversion (BIS) ddPCR and Illumina DNA methylation array.
Results
The RE ddPCR cg05575921 assay appeared concordant with BIS ddPCR (r2 = 0.94, P < 0.0001) and, when compared with the Illumina array, had significantly better smoking status classification performance for current versus never smoked (AUC 0.96 versus 0.93, P < 0.04) and current versus ex-smoker (AUC 0.88 versus 0.83, P < 0.04) comparisons.
Conclusions
The RE ddPCR cg05575921 assay accurately predicts smoking status and could be a useful component of ‘precision-medicine’ chronic disease risk screening tools.
Funder
Cancer Research Trust John Gavin Fellowship
Health Research Council of New Zealand
Genomics Aotearoa
Publisher
Springer Science and Business Media LLC